No. 79 / 2 October 2025

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

ANNOUNCEMENT

According to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations, as subsequently amended and supplemented, and the provisions of the Bucharest Stock Exchange Code

Report Date: 2 October 2025

Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company")

Registered Office: Bucharest, 365 Calea Grivitei, district 1, Romania

Telephone / Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J1996003709402

EUID: ROONRC.J1996003709402

Subscribed and paid-in share capital: RON 132,870,492

Total number of shares: 531,481,968 (out of which 665,983 shares without voting rights and 530,815,985 shares with voting rights)

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Important events to report:

Management transactions as per art. 19 of EU Reg. 596/2014 on market abuse

Med Life S.A. informs investors on the transactions with Company's shares that fall under art. 19 of EU Regulation 596/2014 on market abuse, carried out by persons discharging managerial responsibilities (PDMR) and / or persons which are closely related to the PDMR.

The transactions were notified to the Company on September 29, 2025 by the persons discharging managerial responsibilities (PDMR) and / or persons which are closely related to the PDMR, in accordance with the provisions of the capital market legislation and are attached to this report.

______________ Mihail Marcu

Chief Executive Officer

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 5,536,270.5 RON